TherapeuticsMD, Inc. (TXMD) KPIs and segments

TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 12/3030% below fair value

$1.82−0.03 (-1.62%)

Close on Nov 12, 2026Market cap $21.07MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive TherapeuticsMD's business

TherapeuticsMD's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024

United States($M)	0.49	0.24	0.53	0.45	0.64	0.17	0.43	0.38	0.10	0.20
Non-U.S.($M)	0.38	0.48	0.37	0.34	0.31	0.22	0.24	0.16	0.13	0.11

Earlier reporting (last reported 2024)1

7 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics

Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-11.

See a number that looks wrong?